1.5 Abstract in rivista

1.5 Abstract in rivista: [2291] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 541 a 560 di 2.291

Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis

2015 Nascimbeni, F; Restivo, L; Masetti, C; Amelia, A; Ballestri, S; Nevola, R; Baldelli, E; Rinaldi, L; Romagnoli, D; Guerrera, B; Zampino, R; Giordano, M; Lonardo, A; Adinolfi, Le

A genic and epigenetic combination therapy for liver cancer

2017 Rinaldi, L; Gianluigi, Franci; Folliero, V; Palomba, L; Isticato, R; Zannella, C; di Francia, R; De Sio, I; Giuseppe, Morelli; Maria, Lastoria; Altucci, L; Carlo, Pedone; Ascione, A; Adinolfi, Le; Galdiero, M

Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis

2018 Petta, S; Adinolfi, Le; Fracanzani, Al; Calvaruso, V; Rini, F; Camma, C; V Di Marco, ; Marrone, A; Nevola, R; Pinto, A; Rinaldi, L; Torres, D; Tuttolomondo, A; Valenti, Gian Lorenzo; Fargion, S; Craxì, A

Bioelectrical impedance analysisfor the assessment of body composition in patients with systemic sclerosis

2018 Cuomo, G.; Guarino, G.; Danzo, F.; Romano, C.; Masini, F.; Ferrara, R.; Gentile, S.; Adinolfi, L. E.; Ciro Pasquale, Romano

Prevalence of the metabolic syndrome in patients with systemic sclerosis

2018 Cuomo, G.; Danzo, F.; Masini, F.; Ferrara, Roberta; Pinotti, E.; Romano, C.; Adinolfi, L. E.

Relationship of the six minute walking test and quality of life in patients with systemic sclerosis

2018 Cuomo, G.; Gjeloshi, K.; Masini, F.; Danzo, F.; Romano, C.; Adinolfi, L. E.

THE PROJECTS OF ARCHITECTURE IN THE CITIES OF THE MEDITERRANEAN

2014 Converti, Fabio

Obsessive-compulsive disorder with comorbid schizotypal personality disorder: A novel clinical form?

2016 Perris, F; Fabrazzo, M; Prisco, V; Giacco, D; Catapano, Francesco

Nor-clozapine Plasma Concentration/daily Clozapine Dose Ratio (Ncz/d): an Index of Response to Clozapine Treatment

2015 7., Prisco V; Iannaccone, T; Fabrazzo, M

Duration of untreated illness and outcome of obsessive-compulsive disorder: A naturalistic follow-up study.

2017 Prisco, V; Perris, F; Iannaccone, T; Fabrazzo, M; Catapano, F

Effect of metformin treatment on metabolic parameters in atypical antipsychotic-treated schizophrenic patients.

2016 Prisco, V; Sorice, S; Franza, F; Fabrazzo, M

Influence of temperamental and character traits on antidepressant response in patients affected by major depressive disorder

2016 2., Prisco V; Di Puorto, C; Fabrazzo, M

Antipsychotic Treatment and Metabolic Syndrome: a Comparison between Schizophrenic and Bipolar Patients.

2015 Prisco, V; Boccardi, M; Fantini, C; Catapano, F; Fabrazzo, M

Pro-BNP as a biomarker of asymptomatic clozapine-related heart dysfunction

2016 Prisco, V.; Petrosino, M.; Fabrazzo, M.

The prokaryotic origin of mitochondria studied by the metalloid tellurium as a valuable tool

2015 De Stefano, M.; Romano, R.; Alifano, P.; Gunge, N.; Miyakawa, I.; Sando, N.; Del, Giudice; Luigi,

The nitric oxide-releasing beta-blocker nebivolol may reduce atherosclerosis in cholesterol-fed rabbits

2007 Napoli, Claudio; Fiorito, Carmela; Williams Ignarro, Sharon; de NIGRIS, Filomena; Schiano, Concetta; Byrns, Robert; Sica, Vincenzo; Rienzo, Monica; Casamassimi, Amelia; Ignarro, Louis J.

Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: an extensive analysis of HBV genome.

2015 Svicher, V; Salpini, R; Colagrossi, L; Battisti, A; Bellocchi, Mc; Alteri, C; Armenia, D; Di Santo, F; Carioti, L; Pollicita, M; Ricciardi, A; Lichtner, M; Mastroianni, C; Paoloni, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Di Paolo, D; Sarrecchia, C; Sarmati, L; Andreoni, M; Angelico, M; Perno, Cf

A hyper-glycosilation of HBV surface major hydrophilic region characterizes HBV reactivation driven by immunosuppression and affects HBsAg recognition in vitro

2014 Salpini, R; Surdo, M; Colagrossi, L; Battisti, A; Pollicita, M; Bertoli, A; Di Santo, F; Becker, C; Mastroianni, C; Marignani, M; Maylin, S; Costance Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Sarmati, L; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf; Svicher, V. A.

Long-Term HDV-RNA Suppression – HBsAg Clearance in Chronic Hepatitis D Following Interferon Therapy

2014 Niro, Ga; Fontana, R; Andriulli, A; Smedile, A; Olivero, A; Ciancio, A; Rizzetto, M; Pittalunga, F; Coppola, N; Wedemeyer, H; Zachou, K; Marrone, A; Fasano, M; Santantonio, T; G. Lotti, G.

Biomedical actvities of anthocyanin extrat derived from the Solanum tuberosum L. Vitelotte

2017 Bontempo, P.

Titolo	Data di pubblicazione	Autore(i)
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis	1-gen-2015	Nascimbeni, F; Restivo, L; Masetti, C; Amelia, A; Ballestri, S; Nevola, R; Baldelli, E; Rinaldi, L; Romagnoli, D; Guerrera, B; Zampino, R; Giordano, M; Lonardo, A; Adinolfi, Le
A genic and epigenetic combination therapy for liver cancer	1-gen-2017	Rinaldi, L; Gianluigi, Franci; Folliero, V; Palomba, L; Isticato, R; Zannella, C; di Francia, R; De Sio, I; Giuseppe, Morelli; Maria, Lastoria; Altucci, L; Carlo, Pedone; Ascione, A; Adinolfi, Le; Galdiero, M
Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis	1-gen-2018	Petta, S; Adinolfi, Le; Fracanzani, Al; Calvaruso, V; Rini, F; Camma, C; V Di Marco, ; Marrone, A; Nevola, R; Pinto, A; Rinaldi, L; Torres, D; Tuttolomondo, A; Valenti, Gian Lorenzo; Fargion, S; Craxì, A
Bioelectrical impedance analysisfor the assessment of body composition in patients with systemic sclerosis	1-gen-2018	Cuomo, G.; Guarino, G.; Danzo, F.; Romano, C.; Masini, F.; Ferrara, R.; Gentile, S.; Adinolfi, L. E.; Ciro Pasquale, Romano
Prevalence of the metabolic syndrome in patients with systemic sclerosis	1-gen-2018	Cuomo, G.; Danzo, F.; Masini, F.; Ferrara, Roberta; Pinotti, E.; Romano, C.; Adinolfi, L. E.
Relationship of the six minute walking test and quality of life in patients with systemic sclerosis	1-gen-2018	Cuomo, G.; Gjeloshi, K.; Masini, F.; Danzo, F.; Romano, C.; Adinolfi, L. E.
THE PROJECTS OF ARCHITECTURE IN THE CITIES OF THE MEDITERRANEAN	1-gen-2014	Converti, Fabio
Obsessive-compulsive disorder with comorbid schizotypal personality disorder: A novel clinical form?	1-gen-2016	Perris, F; Fabrazzo, M; Prisco, V; Giacco, D; Catapano, Francesco
Nor-clozapine Plasma Concentration/daily Clozapine Dose Ratio (Ncz/d): an Index of Response to Clozapine Treatment	1-gen-2015	7., Prisco V; Iannaccone, T; Fabrazzo, M
Duration of untreated illness and outcome of obsessive-compulsive disorder: A naturalistic follow-up study.	1-gen-2017	Prisco, V; Perris, F; Iannaccone, T; Fabrazzo, M; Catapano, F
Effect of metformin treatment on metabolic parameters in atypical antipsychotic-treated schizophrenic patients.	1-gen-2016	Prisco, V; Sorice, S; Franza, F; Fabrazzo, M
Influence of temperamental and character traits on antidepressant response in patients affected by major depressive disorder	1-gen-2016	2., Prisco V; Di Puorto, C; Fabrazzo, M
Antipsychotic Treatment and Metabolic Syndrome: a Comparison between Schizophrenic and Bipolar Patients.	1-gen-2015	Prisco, V; Boccardi, M; Fantini, C; Catapano, F; Fabrazzo, M
Pro-BNP as a biomarker of asymptomatic clozapine-related heart dysfunction	1-gen-2016	Prisco, V.; Petrosino, M.; Fabrazzo, M.
The prokaryotic origin of mitochondria studied by the metalloid tellurium as a valuable tool	1-gen-2015	De Stefano, M.; Romano, R.; Alifano, P.; Gunge, N.; Miyakawa, I.; Sando, N.; Del, Giudice; Luigi,
The nitric oxide-releasing beta-blocker nebivolol may reduce atherosclerosis in cholesterol-fed rabbits	1-gen-2007	Napoli, Claudio; Fiorito, Carmela; Williams Ignarro, Sharon; de NIGRIS, Filomena; Schiano, Concetta; Byrns, Robert; Sica, Vincenzo; Rienzo, Monica; Casamassimi, Amelia; Ignarro, Louis J.
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: an extensive analysis of HBV genome.	1-gen-2015	Svicher, V; Salpini, R; Colagrossi, L; Battisti, A; Bellocchi, Mc; Alteri, C; Armenia, D; Di Santo, F; Carioti, L; Pollicita, M; Ricciardi, A; Lichtner, M; Mastroianni, C; Paoloni, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Di Paolo, D; Sarrecchia, C; Sarmati, L; Andreoni, M; Angelico, M; Perno, Cf
A hyper-glycosilation of HBV surface major hydrophilic region characterizes HBV reactivation driven by immunosuppression and affects HBsAg recognition in vitro	1-gen-2014	Salpini, R; Surdo, M; Colagrossi, L; Battisti, A; Pollicita, M; Bertoli, A; Di Santo, F; Becker, C; Mastroianni, C; Marignani, M; Maylin, S; Costance Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Sarmati, L; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf; Svicher, V. A.
Long-Term HDV-RNA Suppression – HBsAg Clearance in Chronic Hepatitis D Following Interferon Therapy	1-gen-2014	Niro, Ga; Fontana, R; Andriulli, A; Smedile, A; Olivero, A; Ciancio, A; Rizzetto, M; Pittalunga, F; Coppola, N; Wedemeyer, H; Zachou, K; Marrone, A; Fasano, M; Santantonio, T; G. Lotti, G.
Biomedical actvities of anthocyanin extrat derived from the Solanum tuberosum L. Vitelotte	1-gen-2017	Bontempo, P.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 541 a 560 di 2.291

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext2290
open1